May 2005
Volume 46, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2005
Short and Long Term Effects of Chronic Ocular Hypertension on the Retinotectal Projection: Neuroprotective Effects of Two Hypotensive Drugs
Author Affiliations & Notes
  • S. Mayor–Torroglosa
    Oftalmologia, Universidad de Murcia, Murcia, Spain
  • G. Ruiz
    Biological Sciences, Allergan Inc., Irvine, CA
  • A. García–Avilés
    Oftalmologia, Universidad de Murcia, Murcia, Spain
  • J.M. Bernal
    Oftalmologia, Universidad de Murcia, Murcia, Spain
  • M.E. Aguilera
    Oftalmologia, Universidad de Murcia, Murcia, Spain
  • I. Cánovas
    Oftalmologia, Universidad de Murcia, Murcia, Spain
  • E. WoldeMussie
    Biological Sciences, Allergan Inc., Irvine, CA
  • L.A. Wheeler
    Biological Sciences, Allergan Inc., Irvine, CA
  • M. Vidal–Sanz
    Oftalmologia, Universidad de Murcia, Murcia, Spain
  • Footnotes
    Commercial Relationships  S. Mayor–Torroglosa, None; G. Ruiz, Allergan Inc. E; A. García–Avilés, None; J.M. Bernal, None; M.E. Aguilera, None; I. Cánovas, None; E. WoldeMussie, Allergan Inc. E; L.A. Wheeler, Allergan Inc. E; M. Vidal–Sanz, None.
  • Footnotes
    Support  FIS C03/13, BFI2002–03742, and Allergan Inc.
Investigative Ophthalmology & Visual Science May 2005, Vol.46, 1277. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      S. Mayor–Torroglosa, G. Ruiz, A. García–Avilés, J.M. Bernal, M.E. Aguilera, I. Cánovas, E. WoldeMussie, L.A. Wheeler, M. Vidal–Sanz; Short and Long Term Effects of Chronic Ocular Hypertension on the Retinotectal Projection: Neuroprotective Effects of Two Hypotensive Drugs . Invest. Ophthalmol. Vis. Sci. 2005;46(13):1277.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: To study the effects of chronic ocular hypertension on the retino–tectal innervation and the possible neuroprotective effects of topically applied Alphagan–P ®, Timoptic ® or saline. Methods: In adult male Wistar rats (350–450 g), ocular hypertension (OHT) was induced in the right eye by laser photocoagulation of episcleral veins (WoldeMussie et al., 2001; IOVS 42:2849). These eyes were treated twice daily with 5 µl of Alphagan–P, Timoptic or 0,9% NaCl. Intraocular pressure (IOP) was measured with a Tono–Pen prior to, and 1, 2, 5 and 9 weeks after lasering in the experimental rats and in an additional group of unlasered (naïve) rats. The neuroprotective effects of antiglaucomatous drugs were investigated by examining at 2 and 9 weeks retinal afferents to the superior colliculus (SC) anterogradely labeled with Cholera Toxin B subunit (CTB) applied to the eyes. Results: Laser treatment to episcleral and limbal veins results 2 w later in a two–fold increase of the IOP. Topical treatment with Alphagan–P– or Timoptic produced significant reductions of the IOP. At 19 or 68 d after lasering, the volume of the retino–tectal projection was 4.11±0.3 (n=14) or 4.09±0.31 (n=16), 3.32±0.47 (n=12) or 3.13±0.74 (n=13), 3.9±0.33 (n=11) or 3.78±0.8 (n=15), and 3.51±0.44 (n=14) or 3.19±0.63 (n=15), for the unlesioned, vehicle–, Alphagan–P–, and Timolol–treated groups of rats, respectively. There were significant reductions in the volume of the retino–tectal projections in the timolol– and vehicle–treated groups both a19 and 68 d after lasering. Conclusions: OHT results in the loss of approximately 19% or 23% of the retino–tectal terminals by 19 or 68 days after lasering. Timoptic treatment did not prevent retino–tectal degeneration, and Alphagan–P–treatement resulted in loss of 5% or 7%, thus providing a statistically significant protection against OHT–induced degeneration of the retinotectal projection. Both Alphagan–P and Timoptic were effective to diminish laser–induced IOP, but only Alphagan–P protected against COHT–induced degeneration of retino–tectal terminals. These results are consistent with previous studies (WoldeMussie et al., 2001, IOVS 42:2849; 2004, GLIA 47:109), showing a similar degree of protection against OHT–induced retinal ganglion cell death.

Keywords: neuroprotection • retina • intraocular pressure 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×